Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Kyowa Hakko Kirin Aims at Becoming Global Specialty Pharma Leveraging Biotechnology
May 26, 2008
- Suzuken: Sales Up 8.7% for Wholesale Business
May 26, 2008
- All-Patient Survey Confirms Enbrel's Safety, Efficacy
May 26, 2008
- Alfresa: Sales Up 11.3% to \1,769 Bil.
May 26, 2008
- Mediceo Paltac: Sales Up 4.1% to \2,255 Bil.
May 26, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 26, 2008
- All Univ. Hospitals Have Adopted Preminent: Banyu
May 26, 2008
- MEDICAL DEVICE NEWS IN BRIEF
May 26, 2008
- Janssen to Switch to Disease-based Marketing System
May 26, 2008
- Actos Inhibits CV Events in Diabetics: Takeda Seminar
May 26, 2008
- Shionogi to Emphasize Renal Protective Effect of Irbetan
May 26, 2008
- NEW PRODUCT
May 26, 2008
- Shionogi: Crestor Drives Sales and Profits
May 26, 2008
- R&D NEWS IN BRIEF
May 19, 2008
- BUSINESS NEWS IN BRIEF
May 19, 2008
- GENERICS NEWS IN BRIEF
May 19, 2008
- Sugi Pharmacy to Adopt Holding Company System
May 19, 2008
- DSP: Operating Profits Down 12.6% due to Increases in R&D Costs
May 19, 2008
- Women's Healthcare Team to Lead Marketing of Lunabell: Nippon Shinyaku
May 19, 2008
- Will Generics Take Off? (3)
May 19, 2008
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…